ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) Stock Income Statement
USA - NASDAQ:ANPC - US03635R2067 - ADR
4.37 USD
-0.25 (-5.41%)
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 15.91M | 17.99M | 20.51M | 10.85M | 10.25M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | 1.18M | 1.39M | 90.00K | 560.00K | 230.00K | |||
| Cost Of Goods | 3.40M | 5.73M | 7.63M | 6.05M | 5.67M | |||
| Gross Profit | 12.51M | 12.25M | 12.88M | 4.80M | 4.58M | |||
| Operating Expenses | 90.71M | 118.30M | 106.01M | 93.88M | 48.19M | |||
| Research and Development | 12.26M | 16.20M | 11.58M | 9.84M | 10.11M | |||
| Selling, General, and Administrative Expenses | 78.45M | 102.10M | 94.43M | 84.41M | 38.67M | |||
| Operating Income | -78.20M | -106.05M | -93.13M | -89.08M | -43.61M | |||
| Interest Income/Expense | -1.37M | -4.33M | -1.82M | -5.64M | -4.14M | |||
| Other Income/Expense | -2.42M | -8.08M | 15.73M | -7.12M | 5.26M | |||
| Non Recurring Items | null | -2.81M | -1.43M | null | null | |||
| Income Before Taxes | -105.47M | -121.27M | -80.65M | -101.84M | -42.50M | |||
| Income Tax | -3.20M | -1.18M | -90.00K | -220.00K | -200.00K | |||
| Net Income | -101.10M | -118.69M | -80.48M | -101.06M | -42.06M | |||
| EBITDA | null | -102.14M | -90.03M | -86.42M | -40.47M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -94.39654 | -174.48072 | -7.19 | -8.76 | -3.65 | |||
| Non GAAP EPS | null | null | null | null | null | |||
| Statistics | ||||||||
| Gross Profit Margin | 78.61% | 68.13% | 62.80% | 44.24% | 44.68% | |||
| Profit Margin | -635.31% | -659.93% | -392.39% | -931.43% | -410.34% | |||
| Operating Profit Margin | -491.45% | -589.60% | -454.07% | -821.01% | -425.46% | |||
All data in CNY